Asahi Glass has acquired Biomeva from Biomeva Holding to expand its business.

The acquirer is a glass company, while the target company is a contract manufacturing business that manufactures and distributes biologics, APIs and therapeutic proteins.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Allergan has acquired all assets of RetroSense Therapeutics LLC to expand its ongoing development programmes.

According to the agreement, RetroSense will receive an upfront payment of $60m, as well as an additional regulatory and commercialisation milestone payments for its proprietary gene therapy RST-100 from Allergan.


Image: Allergan Plc has acquired all the assets of RetroSense Therapeutics LLC. Photo: Courtesy of Coolcaesar at the English language Wikipedia.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Science 37 has won the Research and Development Award in the Site Innovation category for its FDA inspected Direct-to-Patient Site model, delivering nationwide access, faster enrollment and higher retention. Explore how its virtual-first, in home approach is reshaping trial operations and accelerating time to data-driven decisions..

Discover the Impact